Skip to Content
Skip to Content

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 11 September 2019. Database contains 222 unique substances/entries.
Filter the list
Latest update:
Date of intention:
Date of RMOA conclusion:

 
200-280-6
56-55-3
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
05/07/2017
Details
233-660-5
10294-40-3
Netherlands
Carcinogenic
Concluded
Appropriate to initiate regulatory risk management action
CLH
SVHC
08/07/2019
Details
200-539-3
62-53-3
Netherlands
Other environmental toxicity
Other human toxicity
Concluded
No need to initiate further regulatory risk management action at this time
None
05/07/2017
Details
232-565-6
9000-90-2
United Kingdom
Respiratory sensitiser
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
12/09/2018
Details
696-364-9
133779-11-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
This substance is identified by SDA Substance Name: N-C12-C18 alkyl propylene diamine and SDA Reporting Number: 16-032-00.
268-957-9
68155-37-3
Sweden
Carcinogenic
Mutagenic
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
292-562-0
90640-43-0
Sweden
STOT RE
Concluded
No need to initiate further regulatory risk management action at this time
None
17/04/2019
Details
-
-
Netherlands
Carcinogenic
Exposure
Mutagenic
STOT RE
Under development
Under development
No suggestion yet
13/04/2017
Details
287-477-0
85535-85-9
Germany
Carcinogenic
Toxic for reproduction
Under development
Under development
No suggestion yet
08/07/2019
Details
203-466-5
107-13-1
Germany
Mutagenic
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
23/09/2014
Details
201-469-6
83-32-9
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
11/12/2015
Details
235-715-9
12607-70-4
France
Carcinogenic
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
23/09/2014
Details
255-288-2
41272-40-6
Netherlands
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
CLH
15/12/2017
Details
217-533-1
1879-09-0
France
Carcinogenic
Mutagenic
Skin sensitiser
Toxic for reproduction
Under development
Under development
No suggestion yet
07/03/2017
Details
400-370-7
-
Finland
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/09/2019
Details
202-679-0
98-54-4
Germany
Endocrine disruption
Other human toxicity
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/03/2017
Details
202-696-3
98-73-7
Belgium
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
209-544-5
584-84-9
Denmark
Aggregated tonnage
Carcinogenic
Exposure
Mutagenic
Widespread use
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
209-544-5
584-84-9
Germany
Bioaccumulation
Carcinogenic
Mutagenic
Persistence
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-681-1
98-56-6
Netherlands
Carcinogenic
Under development
Under development
No suggestion yet
09/11/2017
Details
250-863-4
31906-04-4
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
Other
05/06/2015
Details
201-250-5
80-09-1
Belgium
Carcinogenic
Endocrine disruption
Mutagenic
Toxic for reproduction
Under development
Under development
No suggestion yet
06/03/2015
Details
254-551-9
39635-79-5
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Pending
On hold
No suggestion yet
23/09/2014
Details
202-966-0
101-68-8
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-966-0
101-68-8
Denmark
Carcinogenic
Mutagenic
Other human toxicity
Persistence
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
210-658-2
620-92-8
Sweden
Endocrine disruption
Other human toxicity
Under development
Under development
No suggestion yet
01/10/2015
Details
225-863-2
5124-30-1
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
226-378-9
5384-21-4
France
Endocrine disruption
Persistence
Toxic for reproduction
Widespread use
Under development
Under development
No suggestion yet
11/03/2016
Details
Bisphenol A; BPA
201-245-8
80-05-7
Germany
Aggregated tonnage
Endocrine disruption
Widespread use
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
Bisphenol A; BPA
201-245-8
80-05-7
France
Endocrine disruption
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
15/08/2017
Details
216-036-7
1478-61-1
Sweden
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
CLH
20/12/2018
Details
201-025-1
77-40-7
France
Endocrine disruption
Under development
Under development
No suggestion yet
07/03/2017
Details
223-861-6
4098-71-9
Sweden
Exposure
Mutagenic
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
09/02/2018
Details
223-861-6
4098-71-9
Germany
Carcinogenic
Exposure
Mutagenic
Other human toxicity
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
202-112-7
91-97-4
Germany
Mutagenic
Persistence
Respiratory sensitiser
Skin sensitiser
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
211-765-7
693-98-1
Sweden
Toxic for reproduction
Under development
Under development
No suggestion yet
10/04/2018
Details
202-039-0
91-08-7
Denmark
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
No need to initiate further regulatory risk management action at this time
None
23/09/2014
Details
202-039-0
91-08-7
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
220-239-6
2682-20-4
Denmark
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
04/05/2015
Details
400-600-6
71868-10-5
Austria
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2019
Details
203-772-9
110-49-6
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
29/11/2018
Details
203-080-7
103-11-7
Sweden
Skin sensitiser
Concluded
No need to initiate further regulatory risk management action at this time
None
15/08/2017
Details
239-622-4
15571-58-1
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
23/09/2014
Details
260-829-0
57583-35-4
Netherlands
Bioaccumulation
Other human toxicity
Persistence
Concluded
Appropriate to initiate regulatory risk management action
Other legislation
05/07/2017
Details
404-360-3
119313-12-1
Austria
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2019
Details
201-289-8
80-54-6
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
02/09/2019
Details
219-470-5
2440-22-4
Germany
Other human toxicity
Persistence
Toxic for reproduction
Under development
Under development
No suggestion yet
05/12/2014
Details
603-051-2
125304-04-3
Germany
Bioaccumulation
Other human toxicity
Persistence
Under development
Under development
No suggestion yet
01/04/2015
Details
253-037-1
36437-37-3
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
221-573-5
3147-75-9
Germany
Bioaccumulation
Other environmental toxicity
Persistence
Under development
Under development
No suggestion yet
05/12/2014
Details

Export search results to:

Categories Display


Route: .live2